CORAL SPRINGS, Fla.--(BUSINESS WIRE)--CyGene Laboratories Inc. (OTC:CYGE) (“the Company”) announced today that it has been made aware of fraudulent schemes against its overseas investors. In one form of this fraud, brokerage companies allege that CyGene is soon to be acquired and are offered much higher than market prices for their shares. Unfortunately, the shareholders that relinquish their stock certificates to these brokerage firms never receive any monies and the shares are sold indiscriminately into the market, driving down the price of the Company stock.
